Trial Outcomes & Findings for Comparing Smoking Cessation Interventions Among Underserved Patients Referred for Lung Cancer Screening (NCT NCT04798664)

NCT ID: NCT04798664

Last Updated: 2026-02-25

Results Overview

The primary outcome measure is sustained abstinence for 6 months, and will require self-report of smoking cessation followed by biochemical confirmation at 2 weeks, 3, and 6 months.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

3228 participants

Primary outcome timeframe

6 months

Results posted on

2026-02-25

Participant Flow

Virtual outreach: 05/17/21-01/17/24. Potentially eligible patients received text messages and/or emails inviting them to complete an eligibility survey. Clinic outreach: 05/17/21-01/17/24. Patients who had not yet completed eligibility screening were handed an iPad with the enrollment URL when coming in for their LCDT appointment. Enrollment concluded on 01/31/24.

Eligible patients had the opportunity to review frequently asked questions and opt out of enrollment. Patients who neither opted out nor clicked 'Complete' to be randomized received an email and/or text message after 14 days, instructing them to notify the team if they did not wish to participate; otherwise, the patient was randomized three days later. This process was called 'last chance to opt out' (LCOO; 03/17/22-01/08/24).

Participant milestones

Participant milestones
Measure
Basic Usual Care
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
Enhanced Usual Care
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians. Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications
Enhanced Usual Care Plus Financial Incentives
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively. Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications Financial Incentives: Financial incentive plan of up to $600 for biochemically-confirmed, sustained abstinence for 6 months.
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner. Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications Financial Incentives: Financial incentive plan of up to $600 for biochemically-confirmed, sustained abstinence for 6 months. Mobile Health Application: Episodic future thinking tool to overcome temporal discounting of future
Overall Study
STARTED
605
889
889
845
Overall Study
COMPLETED
605
883
888
844
Overall Study
NOT COMPLETED
0
6
1
1

Reasons for withdrawal

Reasons for withdrawal
Measure
Basic Usual Care
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
Enhanced Usual Care
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians. Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications
Enhanced Usual Care Plus Financial Incentives
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively. Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications Financial Incentives: Financial incentive plan of up to $600 for biochemically-confirmed, sustained abstinence for 6 months.
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner. Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications Financial Incentives: Financial incentive plan of up to $600 for biochemically-confirmed, sustained abstinence for 6 months. Mobile Health Application: Episodic future thinking tool to overcome temporal discounting of future
Overall Study
Death
0
6
1
1

Baseline Characteristics

Comparing Smoking Cessation Interventions Among Underserved Patients Referred for Lung Cancer Screening

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Basic Usual Care
n=605 Participants
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
Enhanced Usual Care
n=889 Participants
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians. Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications
Enhanced Usual Care Plus Financial Incentives
n=889 Participants
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively. Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications Financial Incentives: Financial incentive plan of up to $600 for biochemically-confirmed, sustained abstinence for 6 months.
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
n=845 Participants
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner. Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications Financial Incentives: Financial incentive plan of up to $600 for biochemically-confirmed, sustained abstinence for 6 months. Mobile Health Application: Episodic future thinking tool to overcome temporal discounting of future
Total
n=3228 Participants
Total of all reporting groups
Age, Continuous
60.9 years
STANDARD_DEVIATION 6.38 • n=24 Participants
61.6 years
STANDARD_DEVIATION 6.70 • n=20 Participants
61.6 years
STANDARD_DEVIATION 6.37 • n=40 Participants
61.7 years
STANDARD_DEVIATION 6.69 • n=565 Participants
61.5 years
STANDARD_DEVIATION 6.55 • n=349 Participants
Sex/Gender, Customized
Woman
337 participants
n=24 Participants
434 participants
n=20 Participants
440 participants
n=40 Participants
411 participants
n=565 Participants
1622 participants
n=349 Participants
Sex/Gender, Customized
Man
184 participants
n=24 Participants
283 participants
n=20 Participants
279 participants
n=40 Participants
255 participants
n=565 Participants
1001 participants
n=349 Participants
Sex/Gender, Customized
Self-describe
1 participants
n=24 Participants
2 participants
n=20 Participants
1 participants
n=40 Participants
5 participants
n=565 Participants
9 participants
n=349 Participants
Sex/Gender, Customized
Missing
83 participants
n=24 Participants
170 participants
n=20 Participants
169 participants
n=40 Participants
174 participants
n=565 Participants
596 participants
n=349 Participants
Sex: Female, Male
Female
384 Participants
n=24 Participants
521 Participants
n=20 Participants
530 Participants
n=40 Participants
513 Participants
n=565 Participants
1948 Participants
n=349 Participants
Sex: Female, Male
Male
221 Participants
n=24 Participants
368 Participants
n=20 Participants
359 Participants
n=40 Participants
332 Participants
n=565 Participants
1280 Participants
n=349 Participants
Race/Ethnicity, Customized
No
581 participants
n=24 Participants
803 participants
n=20 Participants
801 participants
n=40 Participants
756 participants
n=565 Participants
2941 participants
n=349 Participants
Race/Ethnicity, Customized
Yes-Cuban
0 participants
n=24 Participants
3 participants
n=20 Participants
1 participants
n=40 Participants
4 participants
n=565 Participants
8 participants
n=349 Participants
Race/Ethnicity, Customized
Yes-Mexican
3 participants
n=24 Participants
38 participants
n=20 Participants
44 participants
n=40 Participants
44 participants
n=565 Participants
129 participants
n=349 Participants
Race/Ethnicity, Customized
Yes-Puerto Rican
18 participants
n=24 Participants
18 participants
n=20 Participants
24 participants
n=40 Participants
26 participants
n=565 Participants
86 participants
n=349 Participants
Race/Ethnicity, Customized
Yes-Other
3 participants
n=24 Participants
27 participants
n=20 Participants
19 participants
n=40 Participants
15 participants
n=565 Participants
64 participants
n=349 Participants
Race/Ethnicity, Customized
American Indian or Alaskan Native
0 participants
n=24 Participants
10 participants
n=20 Participants
2 participants
n=40 Participants
6 participants
n=565 Participants
18 participants
n=349 Participants
Race/Ethnicity, Customized
Asian or Asian American
3 participants
n=24 Participants
26 participants
n=20 Participants
25 participants
n=40 Participants
23 participants
n=565 Participants
77 participants
n=349 Participants
Race/Ethnicity, Customized
Native Hawaiian or Other Pacific Islander
0 participants
n=24 Participants
2 participants
n=20 Participants
4 participants
n=40 Participants
2 participants
n=565 Participants
8 participants
n=349 Participants
Race/Ethnicity, Customized
Black or African American
154 participants
n=24 Participants
238 participants
n=20 Participants
224 participants
n=40 Participants
207 participants
n=565 Participants
823 participants
n=349 Participants
Race/Ethnicity, Customized
White or Caucasian
425 participants
n=24 Participants
552 participants
n=20 Participants
583 participants
n=40 Participants
549 participants
n=565 Participants
2109 participants
n=349 Participants
Race/Ethnicity, Customized
Multiple
13 participants
n=24 Participants
22 participants
n=20 Participants
13 participants
n=40 Participants
20 participants
n=565 Participants
68 participants
n=349 Participants
Race/Ethnicity, Customized
Other
9 participants
n=24 Participants
36 participants
n=20 Participants
35 participants
n=40 Participants
38 participants
n=565 Participants
118 participants
n=349 Participants
Race/Ethnicity, Customized
Decline
1 participants
n=24 Participants
3 participants
n=20 Participants
3 participants
n=40 Participants
0 participants
n=565 Participants
7 participants
n=349 Participants
Education
Did not graduate from high school
91 participants
n=24 Participants
107 participants
n=20 Participants
104 participants
n=40 Participants
91 participants
n=565 Participants
393 participants
n=349 Participants
Education
High school degree or equivalent
256 participants
n=24 Participants
348 participants
n=20 Participants
352 participants
n=40 Participants
344 participants
n=565 Participants
1300 participants
n=349 Participants
Education
Some college but no degree
102 participants
n=24 Participants
160 participants
n=20 Participants
148 participants
n=40 Participants
161 participants
n=565 Participants
571 participants
n=349 Participants
Education
Associate or Bachelor Degree
127 participants
n=24 Participants
223 participants
n=20 Participants
229 participants
n=40 Participants
210 participants
n=565 Participants
789 participants
n=349 Participants
Education
Graduate degree
29 participants
n=24 Participants
51 participants
n=20 Participants
56 participants
n=40 Participants
39 participants
n=565 Participants
175 participants
n=349 Participants
Income (%FPL)
0-199% Federal Poverty Line
307 participants
n=24 Participants
401 participants
n=20 Participants
418 participants
n=40 Participants
393 participants
n=565 Participants
1519 participants
n=349 Participants
Income (%FPL)
200-400+% Federal Poverty Line
295 participants
n=24 Participants
486 participants
n=20 Participants
466 participants
n=40 Participants
448 participants
n=565 Participants
1695 participants
n=349 Participants
Income (%FPL)
Missing
3 participants
n=24 Participants
2 participants
n=20 Participants
5 participants
n=40 Participants
4 participants
n=565 Participants
14 participants
n=349 Participants
Rurality (self-report)
Yes, rural
253 participants
n=24 Participants
325 participants
n=20 Participants
317 participants
n=40 Participants
308 participants
n=565 Participants
1203 participants
n=349 Participants
Rurality (self-report)
Don't know: Rural ZIP (not RUCA1)
12 participants
n=24 Participants
12 participants
n=20 Participants
12 participants
n=40 Participants
12 participants
n=565 Participants
48 participants
n=349 Participants
Rurality (self-report)
Don't know: RUCA1
46 participants
n=24 Participants
65 participants
n=20 Participants
76 participants
n=40 Participants
65 participants
n=565 Participants
252 participants
n=349 Participants
Rurality (self-report)
No, not rural
294 participants
n=24 Participants
487 participants
n=20 Participants
484 participants
n=40 Participants
460 participants
n=565 Participants
1725 participants
n=349 Participants
Tobacco/ Nicotine dependence
1-4
71 participants
n=24 Participants
109 participants
n=20 Participants
118 participants
n=40 Participants
111 participants
n=565 Participants
409 participants
n=349 Participants
Tobacco/ Nicotine dependence
5-7
77 participants
n=24 Participants
96 participants
n=20 Participants
105 participants
n=40 Participants
108 participants
n=565 Participants
386 participants
n=349 Participants
Tobacco/ Nicotine dependence
8-10
96 participants
n=24 Participants
182 participants
n=20 Participants
185 participants
n=40 Participants
178 participants
n=565 Participants
641 participants
n=349 Participants
Tobacco/ Nicotine dependence
11-20
264 participants
n=24 Participants
366 participants
n=20 Participants
340 participants
n=40 Participants
320 participants
n=565 Participants
1290 participants
n=349 Participants
Tobacco/ Nicotine dependence
21-30
73 participants
n=24 Participants
109 participants
n=20 Participants
103 participants
n=40 Participants
103 participants
n=565 Participants
388 participants
n=349 Participants
Tobacco/ Nicotine dependence
31 or more
24 participants
n=24 Participants
27 participants
n=20 Participants
38 participants
n=40 Participants
25 participants
n=565 Participants
114 participants
n=349 Participants
LDCT screening results
Concerning
248 Participants
n=24 Participants
255 Participants
n=20 Participants
259 Participants
n=40 Participants
232 Participants
n=565 Participants
994 Participants
n=349 Participants
LDCT screening results
Reassuring
357 Participants
n=24 Participants
634 Participants
n=20 Participants
630 Participants
n=40 Participants
613 Participants
n=565 Participants
2234 Participants
n=349 Participants
Number of prior LDCT screening tests (prior to enrollment)
1.64 number of scans
STANDARD_DEVIATION 1.63 • n=24 Participants
1.39 number of scans
STANDARD_DEVIATION 1.48 • n=20 Participants
1.39 number of scans
STANDARD_DEVIATION 1.49 • n=40 Participants
1.37 number of scans
STANDARD_DEVIATION 1.43 • n=565 Participants
1.43 number of scans
STANDARD_DEVIATION 1.50 • n=349 Participants
Presence of mental health diagnoses
Yes
289 Participants
n=24 Participants
384 Participants
n=20 Participants
431 Participants
n=40 Participants
382 Participants
n=565 Participants
1486 Participants
n=349 Participants
Presence of mental health diagnoses
No
312 Participants
n=24 Participants
495 Participants
n=20 Participants
449 Participants
n=40 Participants
457 Participants
n=565 Participants
1713 Participants
n=349 Participants
Presence of mental health diagnoses
Missing
4 Participants
n=24 Participants
10 Participants
n=20 Participants
9 Participants
n=40 Participants
6 Participants
n=565 Participants
29 Participants
n=349 Participants
Time of accrual
Enrolled on or before 9/18/2022 (pandemic era)
270 Participants
n=24 Participants
367 Participants
n=20 Participants
372 Participants
n=40 Participants
331 Participants
n=565 Participants
1340 Participants
n=349 Participants
Time of accrual
Enrolled after 9/18/2022
335 Participants
n=24 Participants
522 Participants
n=20 Participants
517 Participants
n=40 Participants
514 Participants
n=565 Participants
1888 Participants
n=349 Participants
Insurance
Commercial
310 Participants
n=24 Participants
453 Participants
n=20 Participants
468 Participants
n=40 Participants
437 Participants
n=565 Participants
1668 Participants
n=349 Participants
Insurance
Medicaid
95 Participants
n=24 Participants
119 Participants
n=20 Participants
105 Participants
n=40 Participants
94 Participants
n=565 Participants
413 Participants
n=349 Participants
Insurance
Medicare
198 Participants
n=24 Participants
315 Participants
n=20 Participants
313 Participants
n=40 Participants
309 Participants
n=565 Participants
1135 Participants
n=349 Participants
Insurance
Self-pay
0 Participants
n=24 Participants
0 Participants
n=20 Participants
1 Participants
n=40 Participants
2 Participants
n=565 Participants
3 Participants
n=349 Participants
Insurance
Missing
2 Participants
n=24 Participants
2 Participants
n=20 Participants
2 Participants
n=40 Participants
3 Participants
n=565 Participants
9 Participants
n=349 Participants
Have Smartphone with Internet
Yes
503 Participants
n=24 Participants
744 Participants
n=20 Participants
742 Participants
n=40 Participants
700 Participants
n=565 Participants
2689 Participants
n=349 Participants
Have Smartphone with Internet
No
102 Participants
n=24 Participants
145 Participants
n=20 Participants
147 Participants
n=40 Participants
145 Participants
n=565 Participants
539 Participants
n=349 Participants
Elixhauser Comorbidity Index (van Walraven)
3.60 units on a scale
STANDARD_DEVIATION 7.58 • n=24 Participants
3.11 units on a scale
STANDARD_DEVIATION 7.27 • n=20 Participants
3.31 units on a scale
STANDARD_DEVIATION 7.50 • n=40 Participants
3.57 units on a scale
STANDARD_DEVIATION 6.63 • n=565 Participants
3.38 units on a scale
STANDARD_DEVIATION 7.24 • n=349 Participants

PRIMARY outcome

Timeframe: 6 months

Population: Seven participants passed away prior to their quit ate assessment. One participant passed away after their 2-week lab assessment.

The primary outcome measure is sustained abstinence for 6 months, and will require self-report of smoking cessation followed by biochemical confirmation at 2 weeks, 3, and 6 months.

Outcome measures

Outcome measures
Measure
Basic Usual Care
n=605 Participants
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
Enhanced Usual Care
n=883 Participants
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians.
Enhanced Usual Care Plus Financial Incentives
n=888 Participants
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively.
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
n=844 Participants
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner.
Biochemically Confirmed Smoking Abstinence Sustained for 6 Months
26 Participants
45 Participants
78 Participants
61 Participants

SECONDARY outcome

Timeframe: 2 weeks, 3 months, 12 months

Population: Seven participants passed away prior to their quit date assessment. One participant passed away after their 2-week lab assessment.

Rates of sustained biochemically confirmed smoking cessation

Outcome measures

Outcome measures
Measure
Basic Usual Care
n=605 Participants
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
Enhanced Usual Care
n=884 Participants
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians.
Enhanced Usual Care Plus Financial Incentives
n=888 Participants
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively.
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
n=844 Participants
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner.
Quit Status (Biochemically Confirmed)
2 weeks
58 Participants
85 Participants
133 Participants
90 Participants
Quit Status (Biochemically Confirmed)
3 months
37 Participants
56 Participants
100 Participants
74 Participants
Quit Status (Biochemically Confirmed)
12 months
23 Participants
35 Participants
62 Participants
40 Participants

SECONDARY outcome

Timeframe: Baseline

The EuroQuol Group's quality of life (EQ-5D-5L) scale is a 25-item validated scale used to assess patients' perceived health-related quality of life across the domains of mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Scale range: -1 to 1 index calculated from SAS package provided by author. Additionally calculating misery score which is sum of scores ranging from 5 to 25. For index, 1 is best possible health, while -1 are states worse than death. For the misery score, higher is worse health.

Outcome measures

Outcome measures
Measure
Basic Usual Care
n=507 Participants
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
Enhanced Usual Care
n=696 Participants
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians.
Enhanced Usual Care Plus Financial Incentives
n=698 Participants
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively.
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
n=658 Participants
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner.
Health-related Quality of Life
Raw Score
10.0 score on a scale
Standard Deviation 3.66
9.76 score on a scale
Standard Deviation 3.68
9.47 score on a scale
Standard Deviation 3.75
9.70 score on a scale
Standard Deviation 3.81
Health-related Quality of Life
Weighted Score
0.637 score on a scale
Standard Deviation 0.302
0.662 score on a scale
Standard Deviation 0.300
0.678 score on a scale
Standard Deviation 0.307
0.655 score on a scale
Standard Deviation 0.317

SECONDARY outcome

Timeframe: Baseline

The Challenges to Stopping Smoking Scale (CSS-21) is a validated 21-item measure to assess patients' perceived barriers to smoking cessation. The CSS-21 has two sub-scales: intrinsic factors (physical, psychological or cognitive aspects of quitting), 9 item intrinsic factors scale from 9-36, and extrinsic factors (social or environmental aspects of quitting), 12 item extrinsic factors scale from 12-43. Total score was also prepared, range 21-79. A higher score means a greater challenge.

Outcome measures

Outcome measures
Measure
Basic Usual Care
n=478 Participants
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
Enhanced Usual Care
n=667 Participants
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians.
Enhanced Usual Care Plus Financial Incentives
n=664 Participants
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively.
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
n=624 Participants
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner.
Perceived Barriers to Cessation
Total
49.4 score on a scale
Standard Deviation 10.2
49.3 score on a scale
Standard Deviation 11.1
49.3 score on a scale
Standard Deviation 11.5
49.2 score on a scale
Standard Deviation 11.7
Perceived Barriers to Cessation
Internal
24.4 score on a scale
Standard Deviation 5.47
24.6 score on a scale
Standard Deviation 5.76
24.5 score on a scale
Standard Deviation 5.84
24.5 score on a scale
Standard Deviation 6.19
Perceived Barriers to Cessation
External
25.0 score on a scale
Standard Deviation 6.27
24.7 score on a scale
Standard Deviation 6.77
24.8 score on a scale
Standard Deviation 6.98
24.7 score on a scale
Standard Deviation 6.79

SECONDARY outcome

Timeframe: Baseline

We will use the 10-item situational measure of self-efficacy related to smoking behavior. This scale measures how sure participants are that they can avoid smoking in different situations. The scale ranges from 10-40, with a higher score demonstrating more self-efficacy.

Outcome measures

Outcome measures
Measure
Basic Usual Care
n=506 Participants
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
Enhanced Usual Care
n=700 Participants
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians.
Enhanced Usual Care Plus Financial Incentives
n=700 Participants
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively.
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
n=183 Participants
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner.
Self-efficacy Related to Cessation Efforts
21.1 score on a scale
Standard Deviation 7.89
20.8 score on a scale
Standard Deviation 7.45
21.3 score on a scale
Standard Deviation 7.40
20.9 score on a scale
Standard Deviation 7.71

SECONDARY outcome

Timeframe: Baseline

The Stages of Change (SOC) is a validated 1-item measure to assess patient's self-reported motivation to quit.

Outcome measures

Outcome measures
Measure
Basic Usual Care
n=509 Participants
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
Enhanced Usual Care
n=707 Participants
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians.
Enhanced Usual Care Plus Financial Incentives
n=710 Participants
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively.
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
n=670 Participants
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner.
Motivation to Quit
No, not thinking of quitting
30 Participants
42 Participants
45 Participants
49 Participants
Motivation to Quit
Yes, within the next 6 months
209 Participants
332 Participants
346 Participants
295 Participants
Motivation to Quit
Yes, within the next 30 days
270 Participants
333 Participants
319 Participants
326 Participants

SECONDARY outcome

Timeframe: Baseline

Temporal discounting is a measure of impulsivity that reflects people's tendencies to discount the value of a reward as a function of how far in the future it would be received. We will use the 5-Trial Adjusting Delay Task to assess temporal discounting. The scale ranges from 0.000110 to 24, with a higher value meaning present is valued more over future gain. K values were calculated in R using the values noted in Koffarnus \& Bickel 2014.

Outcome measures

Outcome measures
Measure
Basic Usual Care
n=470 Participants
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
Enhanced Usual Care
n=632 Participants
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians.
Enhanced Usual Care Plus Financial Incentives
n=643 Participants
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively.
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
n=589 Participants
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner.
Temporal ("Delay") Discounting
1.94 k value
Standard Deviation 6.04
1.67 k value
Standard Deviation 5.69
2.20 k value
Standard Deviation 6.43
1.84 k value
Standard Deviation 5.94

SECONDARY outcome

Timeframe: 6 months

The EuroQuol Group's quality of life (EQ-5D-5L) scale is a 25-item validated scale used to assess patients' perceived health-related quality of life across the domains of mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Scale range: -1 to 1 index calculated from SAS package provided by author. Additionally calculating misery score which is sum of scores ranging from 5 to 25. For index, 1 is best possible health, while -1 are states worse than death. For the misery score, higher is worse health.

Outcome measures

Outcome measures
Measure
Basic Usual Care
n=236 Participants
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
Enhanced Usual Care
n=340 Participants
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians.
Enhanced Usual Care Plus Financial Incentives
n=355 Participants
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively.
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
n=287 Participants
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner.
Health-related Quality of Life
Raw Score
10.1 score on a scale
Standard Deviation 3.61
9.66 score on a scale
Standard Deviation 3.86
9.62 score on a scale
Standard Deviation 3.72
9.81 score on a scale
Standard Deviation 3.89
Health-related Quality of Life
Weighted Score
0.626 score on a scale
Standard Deviation 0.299
0.664 score on a scale
Standard Deviation 0.316
0.667 score on a scale
Standard Deviation 0.304
0.650 score on a scale
Standard Deviation 0.313

SECONDARY outcome

Timeframe: 6 months

The Challenges to Stopping Smoking Scale (CSS-21) is a validated 21-item measure to assess patients' perceived barriers to smoking cessation. The CSS-21 has two sub-scales: intrinsic factors (physical, psychological or cognitive aspects of quitting), 9 item intrinsic factors scale from 9-36, and extrinsic factors (social or environmental aspects of quitting), 12 item extrinsic factors scale from 12-43. Total score was also prepared, range 21-79. A higher score means a greater challenge.

Outcome measures

Outcome measures
Measure
Basic Usual Care
n=230 Participants
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
Enhanced Usual Care
n=332 Participants
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians.
Enhanced Usual Care Plus Financial Incentives
n=349 Participants
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively.
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
n=278 Participants
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner.
Perceived Barriers to Cessation
Total
44.9 score on a scale
Standard Deviation 12.0
45.6 score on a scale
Standard Deviation 11.9
44.5 score on a scale
Standard Deviation 12.1
42.8 score on a scale
Standard Deviation 12.0
Perceived Barriers to Cessation
Internal
22.2 score on a scale
Standard Deviation 6.30
22.5 score on a scale
Standard Deviation 6.28
22.1 score on a scale
Standard Deviation 6.46
21.4 score on a scale
Standard Deviation 6.55
Perceived Barriers to Cessation
External
22.7 score on a scale
Standard Deviation 6.89
23.1 score on a scale
Standard Deviation 7.00
22.4 score on a scale
Standard Deviation 6.96
21.4 score on a scale
Standard Deviation 6.53

SECONDARY outcome

Timeframe: 6 months

We will use the 10-item situational measure of self-efficacy related to smoking behavior. This scale measures how sure participants are that they can avoid smoking in different situations. The scale ranges from 10-40, with a higher score demonstrating more self-efficacy.

Outcome measures

Outcome measures
Measure
Basic Usual Care
n=237 Participants
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
Enhanced Usual Care
n=335 Participants
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians.
Enhanced Usual Care Plus Financial Incentives
n=362 Participants
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively.
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
n=291 Participants
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner.
Self-efficacy Related to Cessation Efforts
27.9 score on a scale
Standard Deviation 8.96
27.8 score on a scale
Standard Deviation 9.09
29.1 score on a scale
Standard Deviation 9.30
29.1 score on a scale
Standard Deviation 9.25

SECONDARY outcome

Timeframe: 6 months

The Stages of Change (SOC) is a validated 1-item measure to assess patient's self-reported motivation to quit.

Outcome measures

Outcome measures
Measure
Basic Usual Care
n=231 Participants
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
Enhanced Usual Care
n=323 Participants
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians.
Enhanced Usual Care Plus Financial Incentives
n=337 Participants
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively.
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
n=280 Participants
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner.
Motivation to Quit
No, not thinking of quitting
8 Participants
10 Participants
8 Participants
6 Participants
Motivation to Quit
Yes, within the next 6 months
104 Participants
121 Participants
134 Participants
108 Participants
Motivation to Quit
Yes, within the next 30 days
119 Participants
192 Participants
195 Participants
166 Participants

SECONDARY outcome

Timeframe: 6 months

Temporal discounting is a measure of impulsivity that reflects people's tendencies to discount the value of a reward as a function of how far in the future it would be received. We will use the 5-Trial Adjusting Delay Task to assess temporal discounting. The scale ranges from 0.000110 to 24, with a higher value meaning present is valued more over future gain. K values were calculated in R using the values noted in Koffarnus \& Bickel 2014.

Outcome measures

Outcome measures
Measure
Basic Usual Care
n=216 Participants
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
Enhanced Usual Care
n=296 Participants
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians.
Enhanced Usual Care Plus Financial Incentives
n=325 Participants
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively.
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
n=254 Participants
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner.
Temporal ("Delay") Discounting
3.31 k value
Standard Deviation 7.67
2.37 k value
Standard Deviation 6.43
2.34 k value
Standard Deviation 6.44
1.75 k value
Standard Deviation 5.42

SECONDARY outcome

Timeframe: 12 months

The EuroQuol Group's quality of life (EQ-5D-5L) scale is a 25-item validated scale used to assess patients' perceived health-related quality of life across the domains of mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Scale range: -1 to 1 index calculated from SAS package provided by author. Additionally calculating misery score which is sum of scores ranging from 5 to 25. For index, 1 is best possible health, while -1 are states worse than death. For the misery score, higher is worse health.

Outcome measures

Outcome measures
Measure
Basic Usual Care
n=247 Participants
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
Enhanced Usual Care
n=366 Participants
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians.
Enhanced Usual Care Plus Financial Incentives
n=361 Participants
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively.
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
n=298 Participants
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner.
Health-related Quality of Life
Raw Score
10.3 score on a scale
Standard Deviation 4.00
9.90 score on a scale
Standard Deviation 3.76
9.33 score on a scale
Standard Deviation 3.65
9.69 score on a scale
Standard Deviation 3.90
Health-related Quality of Life
Weighted Score
0.612 score on a scale
Standard Deviation 0.334
0.645 score on a scale
Standard Deviation 0.308
0.689 score on a scale
Standard Deviation 0.297
0.661 score on a scale
Standard Deviation 0.312

SECONDARY outcome

Timeframe: 12 months

The Challenges to Stopping Smoking Scale (CSS-21) is a validated 21-item measure to assess patients' perceived barriers to smoking cessation. The CSS-21 has two sub-scales: intrinsic factors (physical, psychological or cognitive aspects of quitting), 9 item intrinsic factors scale from 9-36, and extrinsic factors (social or environmental aspects of quitting), 12 item extrinsic factors scale from 12-43. Total score was also prepared, range 21-79. A higher score means a greater challenge.

Outcome measures

Outcome measures
Measure
Basic Usual Care
n=238 Participants
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
Enhanced Usual Care
n=359 Participants
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians.
Enhanced Usual Care Plus Financial Incentives
n=348 Participants
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively.
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
n=292 Participants
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner.
Perceived Barriers to Cessation
Total
45.0 score on a scale
Standard Deviation 11.07
45.5 score on a scale
Standard Deviation 12.1
43.1 score on a scale
Standard Deviation 11.5
44.0 score on a scale
Standard Deviation 13.1
Perceived Barriers to Cessation
Internal
22.4 score on a scale
Standard Deviation 6.21
22.5 score on a scale
Standard Deviation 6.34
21.5 score on a scale
Standard Deviation 6.39
21.8 score on a scale
Standard Deviation 6.98
Perceived Barriers to Cessation
External
22.6 score on a scale
Standard Deviation 6.83
23.0 score on a scale
Standard Deviation 6.90
21.6 score on a scale
Standard Deviation 6.36
22.1 score on a scale
Standard Deviation 7.22

SECONDARY outcome

Timeframe: 12 months

We will use the 10-item situational measure of self-efficacy related to smoking behavior. This scale measures how sure participants are that they can avoid smoking in different situations. The scale ranges from 10-40, with a higher score demonstrating more self-efficacy.

Outcome measures

Outcome measures
Measure
Basic Usual Care
n=247 Participants
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
Enhanced Usual Care
n=365 Participants
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians.
Enhanced Usual Care Plus Financial Incentives
n=360 Participants
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively.
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
n=297 Participants
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner.
Self-efficacy Related to Cessation Efforts
26.8 score on a scale
Standard Deviation 9.43
27.4 score on a scale
Standard Deviation 9.19
28.8 score on a scale
Standard Deviation 9.27
27.9 score on a scale
Standard Deviation 9.64

SECONDARY outcome

Timeframe: 12 months

The Stages of Change (SOC) is a validated 1-item measure to assess patient's self-reported motivation to quit.

Outcome measures

Outcome measures
Measure
Basic Usual Care
n=241 Participants
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
Enhanced Usual Care
n=355 Participants
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians.
Enhanced Usual Care Plus Financial Incentives
n=341 Participants
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively.
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
n=296 Participants
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner.
Motivation to Quit
Yes, within the next 6 months
104 Participants
144 Participants
133 Participants
123 Participants
Motivation to Quit
Yes, within the next 30 days
125 Participants
194 Participants
192 Participants
162 Participants
Motivation to Quit
No, not thinking of quitting
12 Participants
17 Participants
16 Participants
11 Participants

SECONDARY outcome

Timeframe: 12 months

Temporal discounting is a measure of impulsivity that reflects people's tendencies to discount the value of a reward as a function of how far in the future it would be received. We will use the 5-Trial Adjusting Delay Task to assess temporal discounting. The scale ranges from 0.000110 to 24, with a higher value meaning present is valued more over future gain. K values were calculated in R using the values noted in Koffarnus \& Bickel 2014.

Outcome measures

Outcome measures
Measure
Basic Usual Care
n=221 Participants
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
Enhanced Usual Care
n=334 Participants
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians.
Enhanced Usual Care Plus Financial Incentives
n=320 Participants
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively.
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
n=276 Participants
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner.
Temporal ("Delay") Discounting
2.33 k value
Standard Deviation 6.30
1.79 k value
Standard Deviation 5.68
1.64 k value
Standard Deviation 5.39
1.47 k value
Standard Deviation 5.00

SECONDARY outcome

Timeframe: 2 weeks, 3 months, 6 months, 12 months

Population: Seven participants passed away before their quit date assessment. One participant passed away after their 2 week lab assessment.

Rates of sustained self-reported cigarette abstinence

Outcome measures

Outcome measures
Measure
Basic Usual Care
n=605 Participants
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
Enhanced Usual Care
n=884 Participants
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians.
Enhanced Usual Care Plus Financial Incentives
n=888 Participants
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively.
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
n=844 Participants
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner.
Self-report Cigarette Abstinence
2 weeks
84 Participants
130 Participants
172 Participants
129 Participants
Self-report Cigarette Abstinence
3 months
46 Participants
66 Participants
114 Participants
79 Participants
Self-report Cigarette Abstinence
6 months
30 Participants
50 Participants
89 Participants
63 Participants
Self-report Cigarette Abstinence
12 months
25 Participants
40 Participants
64 Participants
45 Participants

SECONDARY outcome

Timeframe: 2 weeks, 3 months, 6 months, 12 months

Population: Seven participants passed away before their quit date assessment. One participant passed away after their 2-week lab assessment.

Rates of sustained self-reported other tobacco abstinence

Outcome measures

Outcome measures
Measure
Basic Usual Care
n=605 Participants
Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes.
Enhanced Usual Care
n=884 Participants
Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians.
Enhanced Usual Care Plus Financial Incentives
n=888 Participants
Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively.
Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application
n=844 Participants
Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner.
Self-report Other Tobacco Abstinence
6 months
30 Participants
50 Participants
89 Participants
63 Participants
Self-report Other Tobacco Abstinence
12 months
25 Participants
40 Participants
64 Participants
45 Participants
Self-report Other Tobacco Abstinence
2 weeks
81 Participants
130 Participants
169 Participants
127 Participants
Self-report Other Tobacco Abstinence
3 months
46 Participants
65 Participants
113 Participants
79 Participants

Adverse Events

Basic Usual Care

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Enhanced Usual Care

Serious events: 0 serious events
Other events: 0 other events
Deaths: 6 deaths

Enhanced Usual Care Plus Financial Incentives

Serious events: 0 serious events
Other events: 0 other events
Deaths: 1 deaths

Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application

Serious events: 0 serious events
Other events: 0 other events
Deaths: 1 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Shira Blady

University of Pennsylvania

Phone: 215-573-3085

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place